The aim was to evaluate the performance of anesthesia depth monitors, Bispectral Index (BIS) and Entropy, during single-agent xenon anesthesia in 17 healthy subjects.


After mask induction with xenon and intubation, anesthesia was continued with xenon only. BIS, State Entropy and Response Entropy, and electroencephalogram were monitored throughout induction, steady-state anesthesia, and emergence. The performance of BIS, State Entropy, and Response Entropy were evaluated with prediction probability, sensitivity, and specificity analyses. The power spectrum of the raw electroencephalogram signal was calculated.


The mean (SD) xenon concentration during anesthesia was 66.4% (2.4%). BIS, State Entropy, and Response Entropy demonstrated low prediction probability values at loss of response (0.455, 0.656, and 0.619) but 1 min after that the values were high (0.804, 0.941, and 0.929). Thereafter, equally good performance was demonstrated for all indices. At emergence, the prediction probability values to distinguish between steady-state anesthesia and return of response for BIS, State Entropy, and Response Entropy were 0.988, 0.892, and 0.992. No statistical differences between the performances of the monitors were observed. Quantitative electroencephalogram analyses showed generalized increase in total power (P < 0.001), delta (P < 0.001) and theta activity (P < 0.001), and increased alpha activity (P = 0.003) in the frontal brain regions.


Electroencephalogram-derived depth of sedation indices BIS and Entropy showed a delay to detect loss of response during induction of xenon anesthesia. Both monitors performed well in distinguishing between conscious and unconscious states during steady-state anesthesia. Xenon-induced changes in electroencephalogram closely resemble those induced by propofol.

XENON is a noble gas that has anesthetic properties supposedly mediated via  antagonism of the N -methyl-d-aspartate (NMDA) receptors.1Xenon has recently been granted marketing authorization for anesthetic maintenance in Germany.2Xenon anesthesia is associated with cardiovascular stability,3,4and recent experimental data also indicate that xenon has both cardioprotective5,6and neuroprotective effects.7–9Because of its potential organ protective effects, xenon has been suggested as a putative neuroanesthetic.

Monitoring the state of hypnosis during general anesthesia has become standard in anesthetic care. Electroencephalogram (EEG) results can be mathematically transformed into numeric indices that can be easily interpreted by the tending anesthesiologist. The use of these indices may decrease the consumption of anesthetics and reduce the incidence of awareness during anesthesia.10,11Nevertheless, these EEG-based indices may not always perform well with all anesthetic agents, particularly with those acting via  the NMDA receptor.12,13 

Because there are only a few previous reports on the use of xenon alone for induction or maintenance of anesthesia,3,14,15the role of anesthesia depth monitors during xenon anesthesia is unclear. Their reliability in measuring xenon-induced hypnosis has even been questioned.16In addition, there are not much data on the effects of surgical concentrations of xenon on quantitative EEG (qEEG) variables in humans.17 

The aim of this study was to assess the performance of anesthesia depth indices, Bispectral Index (BIS) and Entropy, during induction and maintenance of single-agent xenon anesthesia in healthy subjects. The power spectrum of the raw EEG signal was studied to observe the effects of xenon on qEEG and for the detailed evaluation of the performance of the EEG-derived indices.

Subjects and Study Design

The study protocol was approved by the local ethical committee (Turku University, Finland) and the National Agency for Medicines and included two separate positron emission tomography studies (results presented separately). In Part I18(n = 9), BIS, State Entropy (SE), and Response Entropy (RE) were recorded during single-agent xenon anesthesia. In Part II (n = 8), we also collected qEEG. Thus, 17 healthy, male, right-handed, nonsmoking volunteers aged 20-27 yr (body mass index 20.7–28.7 kg/m2) were enrolled after giving written informed consent in this open, nonrandomized study. The subjects underwent a thorough physical examination including laboratory testing. All subjects were considered as American Society of Anesthesiologists I class and had no history of drug allergies or drug abuse, and none was receiving ongoing medication. Subjects fasted overnight and refrained from using alcohol or any medication for 48 h before anesthesia.

The unpremedicated subjects were anesthetized using mask induction with 63% target end-tidal concentration of xenon, considered as approximately 1 minimum alveolar concentration (MAC).19Anesthesia was continued with closed-system mechanical ventilation with xenon as the single anesthetic. After a 2-h period, xenon was discontinued and the subjects were allowed to recover. During anesthesia, the volunteers were not subjected to any noxious interventions as they only underwent repeated noninvasive positron emission tomography scans.


On arrival at the study premises, a forearm vein was cannulated for drug administration, and the radial artery was cannulated for blood sampling and invasive blood pressure monitoring. Physiologic saline was given intravenously at a rate of 100 ml/h throughout anesthesia, after which time the fluid infusion was changed to 5% glucose. Monitoring included invasive blood pressure, pulse oximetry, five-lead electrocardiogram, muscle relaxation (train-of-four), and nasopharyngeal temperature (GE Datex-Ohmeda S/5 anesthesia monitor; GE Healthcare, Helsinki, Finland). All data were automatically recorded throughout the study: vital parameters at 10-s intervals and waveforms at their corresponding sample frequencies (S/5 Collect Software, GE Healthcare). In addition, airway pressure, and concentrations of oxygen, carbon dioxide, and xenon in the ventilation circuit were recorded during anesthesia. Repeated blood gas analyses were performed during anesthesia using a portable device (i -STAT; Abbott Laboratories, Birmingham, UK) to adjust and maintain normoventilation.

Depth of sedation was monitored with BIS® (BIS XP, algorithm version 4.0, smoothing rate 15 s) and Entropy (Entropy module; GE Healthcare) indices throughout anesthesia as recommended by the manufacturers. The skin of the forehead was prepared with alcohol, and disposable BIS (Aspect Medical Systems, Natick, MA) and Entropy sensors (GE Healthcare) were placed on the forehead in close proximity. The sides of temporal electrodes were randomized. The active temporal electrode was placed to the right for BIS in nine subjects and for Entropy in eight subjects.

BIS is a weighted sum of three variables derived from bispectral (0.5–47 Hz), spectral (11–47 Hz), and time domain contents of EEG.20For easier interpretation, these variables were transformed into BIS scale from 0 to 100. Values close to the maximum of 100 indicate state of awareness and values less than 40 indicate deep hypnotic state.

Entropy module computes the time frequency-balanced spectral entropy using a combination of time and frequency domain EEG measures. As a result, the monitor generates two indices, SE and RE, which are calculated from different frequency ranges of the raw EEG signal. SE is derived from the frequency range of 0.8–32 Hz consisting of mainly EEG activity, whereas RE is derived from the range of 0.8–47 Hz and includes muscle activity from the muscles of the forehead.21SE and RE are scaled in ranges of 0-91 and 0–100, respectively.

qEEG Recording

EEG was continuously recorded throughout the study with four-channel digital EEG equipment (GE Datex-Ohmeda S/5™ EEG Module; GE Healthcare) and stored online (S/5 Collect software; GE Healthcare). EEG signal sample rate was 100 Hz and pass-band was 0.5–30 Hz. Ag- AgCl electrodes and the International 10–20 Electrode Placement System were used. Bipolar montage included the F4–C4, F3–C3, T8–O2, and T7–O1 derivations covering the midfrontal-central and posterior temporal-occipital regions of both hemispheres. The skin was prepared to keep the electrode impedance under 5 kΩ, and the electrodes were fixed with electrode paste (Grass-paste; Astro-Medical; Grass Instrument Division, W. Warwick, RI). The EEG signal was further processed using commercial software (Matlab 6.5, The Mathworks Inc., Natick, MA). Raw EEG data were visually analyzed offline, and artifact-contaminated EEG segments were excluded. Only epochs without high-amplitude artifacts, caused by limb or eye movements, were included in power spectral analyses with an epoch length of 4 s. Absolute power spectra (μV2/Hz) of each epoch were obtained with the psd-function of the software. The psd-function uses fast Fourier transform with Hanning windowing. Power spectra from individual epochs were averaged to obtain final power spectra for each analysis period. Power spectrum analysis was performed during two time periods: awake baseline data before xenon administration (6-184 epochs depending on the amount of artifact-free EEG) and a 5-min period during steady-state anesthesia at least 30 min after intubation (73–75 epochs). Artifacts during loss of response (LOR) and return of response (ROR) did not allow qEEG analysis at those time points. Absolute band powers (μV2) were calculated from the following bands: total power (1.0-30.0 Hz), delta (1.0–3.25 Hz), theta (3.5–8.0 Hz), alpha (8.25–13.0 Hz), and beta (13.25–30.0 Hz). In addition, 95% spectral edge frequency and relative power for each band were calculated.


Denitrogenation of the subjects was performed by having them breathe 100% oxygen through a tight 5-cm H2O continuous positive airway pressure mask for 1 h. After the denitrogenation period, the subjects were told to hold their breath to avoid any breathing of room air while the pressure mask was changed to a tightly fitting regular face mask connected to the closed loop anesthesia ventilator (PhysioFlex, Dräger, Lübeck, Germany).22Thereafter, anesthesia was induced by changing the inhaled oxygen concentration from 100% to 21%, thus increasing the xenon concentration in the gas mixture. The subjects continued breathing spontaneously via  the face mask. Xenon concentration increase was facilitated by flushing the breathing system with a mixture of xenon 75% and oxygen 25% with the aim of reaching 63-68% end-tidal xenon concentration (i.e. , 1 MAC).19Upon LOR, muscle relaxation was immediately induced by administering a 0.8-mg/kg bolus of rocuronium (Esmeron 10 mg/ml, Organon, Helsinki, Finland), and tracheal intubation was performed when complete muscle relaxation was achieved. Anesthesia was continued with xenon only in oxygen. Additional 10- to 20-mg bolus doses of rocuronium were given to maintain muscle relaxation at one twitch of train-of-four. In case of obvious pain reaction because of intubation (rapid elevation in blood pressure or heart rate or other clinical signs of insufficient anesthesia), subjects were given a single 25-μg intravenous dose of remifentanil (Ultiva; GlaxoSmithKline, Helsinki, Finland). The time interval between opioid administration and the period of steady-state anesthesia was longer than 30 min. A warming blanket (BairHugger; Arizant Healthcare Inc, Eden Prairie, MN) was used to stabilize body temperature. After approximately 2 h, xenon was discontinued and muscle relaxation was reversed with a combination of neostigmine and glycopyrrolate (Robinul-Neostigmine; Wyeth Lederle, Helsinki, Finland). Subjects were extubated as they recovered spontaneous breathing and regained responsiveness. The first two subjects were given antiemetics when nausea occurred. Thereafter, antiemetics were given prophylactically before emergence to all other subjects. The antiemetics included dehydrobenzperidol (DHBP 1.25 mg/ml; OTL Pharma, Paris, France), dexametasone (Oradexon 5 mg/ml; Organon), and ondansetron (Zofran 2 mg/ml; GlaxoSmithKline). The subjects were monitored for stable vital signs for at least 1 h, and they were discharged according to our hospital’s criteria for ambulatory surgery patients. Subjects completed a modified structured questionnaire by Brice et al.  23on possible awareness during anesthesia and possible hallucinations immediately after ROR and 1 d and 6 wk after anesthesia.

Predetermined clinical events during anesthesia were LOR, intubation, steady-state anesthesia, and ROR. Reaction was assessed at 10-s intervals by requesting the subject to squeeze the investigator’s hand twice. LOR was interpreted as a failure to execute this task. ROR was defined as an adequate response to verbal command after termination of xenon administration. The hemodynamic response to tracheal intubation was determined as the maximal value of heart rate and arterial blood pressures within a 10-min period after intubation compared with the value 1 min before intubation.

Statistical Analysis

Prediction probability (PK) was calculated to evaluate how accurately BIS, RE, or SE distinguishes among different time points of anesthesia. A value of PK= 0.5 means that the indicator predicts the observed anesthetic depths no better than a 50/50 chance, and a value of PK= 1.0 means that the indicator always predicts the observed anesthetic depths correctly. PKand its SE, which was estimated with the jackknife method, were based on the assumption that all assessments were independent. A Student’s t  test with Bonferroni correction was used to evaluate whether the PKfor one variable was different from another one.24A custom spreadsheet macro PKMACRO was used in PKanalysis.24 

PKanalysis was performed for awake versus  LOR, LOR versus  intubation, and steady-state anesthesia versus  ROR. To determine the delay of the indices to indicate LOR, PKanalyses 1, 2, 3, and 4 min after LOR were performed. BIS and Entropy data for the PKanalysis were single values just before start of xenon induction (awake), immediately after LOR, just before intubation, during steady-state anesthesia, and immediately after ROR.

Sensitivity and specificity were calculated to evaluate whether BIS, RE, or SE correctly classify the responsiveness and unresponsiveness states. Sensitivity and specificity were calculated from pooled data of all subjects over two 10-min periods, first 5 min before and after the LOR and similarly before and after the ROR. Sensitivity was defined as the proportion of data points taken during the responsiveness state and indicating responsiveness. Specificity was defined as the proportion of data points taken during the unresponsiveness state and indicating unresponsiveness. Cutoff values for sensitivity and specificity for the indices were obtained from receiver operating characteristics curve. Optimal cutoff values for each variable were defined by maximizing the sum of sensitivity and specificity. In addition, specificity was derived with the cutoff value resulting in 100% sensitivity, which has been stated as an essential feature of the anesthetic depth monitor.25Sensitivity and specificity were calculated with commercial software (Matlab 6.5, The Mathworks Inc.).

Statistical Analysis of the Vital Parameters and qEEG

There were no statistically significant hemisphere-by-derivation interactions in qEEG; therefore, the right hemisphere was selected for further analysis. The repeated-measures analysis of variance model, including the condition (baseline/anesthesia) and derivation (frontal/occipital) as the within factors, was fitted to the qEEG variables. All main effects and interaction effects were analyzed. Absolute qEEG variables were log-transformed before fitting the model.

Vital monitoring variables were analyzed with a repeated-measures analysis of variance model using the hypnotic state as a within factor. The pair-wise comparisons, including estimates and statistical tests among different conditions (baseline/induction/anesthesia) were performed using the linear contrasts of the same model. The 95% confidence intervals were calculated for the estimates. To estimate the effect of remifentanil on studied variables, another repeated-measures analysis of variance model was fitted, including the condition as a within factor and the use of remifentanil (no/yes) as a between factor. A two-sided P  value of less than 0.05 was considered statistically significant. Statistical analysis was conducted with SAS (version 8.2; SAS Institute Inc., Cary, NC).

All subjects were successfully anesthetized, and the mean (SD) xenon concentration during anesthesia was 66.4% (2.4%). The mean length of anesthesia was 1.9 (0.4) hours. Six subjects (35.3%; five in Part I and one in Part II) were given a 25-μg bolus dose of remifentanil because of pain reaction to intubation. Use of remifentanil did not have statistically significant effects on the BIS, SE, RE, or hemodynamic results. LOR was achieved 216 (91) s after xenon was started. After xenon administration was terminated, the mean time for ROR was 219 (91) s. ROR could not be determined for two subjects because of residual muscle relaxation.

BIS and Entropy

The median values and interquartile ranges for BIS, SE, and RE at awake, LOR, steady-state anesthesia, and ROR are presented in table 1. At LOR, the median values for BIS, SE, and RE were 98, 88, and 98; at ROR, respective values were 70, 41, and 61. The corresponding values throughout anesthesia are presented in figure 1.

Table 1. BIS, SE, and RE 

Table 1. BIS, SE, and RE 
Table 1. BIS, SE, and RE 

Fig. 1. Median values and interquartile ranges for bispectral index (  A ), Response Entropy (  B ), and State Entropy (  C ) at loss of response (LOR) and return of response (ROR) during xenon anesthesia. Data are presented for pooled data over all subjects during two time periods: first from 5 min before loss of response and 40 min thereafter, and second from 20 min before return of response and 10 min thereafter. The length of anesthesia was slightly different in each individual with mean (SD) length of 1.9 (0.4) h. The increase in the indices seen soon after loss of response is most probably the result of painful stimulus induced by intubation. 

Fig. 1. Median values and interquartile ranges for bispectral index (  A ), Response Entropy (  B ), and State Entropy (  C ) at loss of response (LOR) and return of response (ROR) during xenon anesthesia. Data are presented for pooled data over all subjects during two time periods: first from 5 min before loss of response and 40 min thereafter, and second from 20 min before return of response and 10 min thereafter. The length of anesthesia was slightly different in each individual with mean (SD) length of 1.9 (0.4) h. The increase in the indices seen soon after loss of response is most probably the result of painful stimulus induced by intubation. 

Close modal

The PKvalues for awake versus  LOR, LOR versus  intubation, and steady-state versus  ROR are presented in table 2. There were no statistical differences in the performance of these monitors at any of these time points. BIS, SE, and RE demonstrated low PKvalues at LOR (table 2). However, in the serial PKanalysis, the values were already high 1 min after LOR; by 4 min after LOR, they all reached the maximum 1.0. There were no statistical differences in the performance among the indices in the serial PKanalysis. Results of PKanalyses 1, 2, 3, and 4 min after LOR are presented in table 3.

Table 2. Prediction Probability (PK) Constants (with Standard Error) 

Table 2. Prediction Probability (PK) Constants (with Standard Error) 
Table 2. Prediction Probability (PK) Constants (with Standard Error) 

Table 3. Serial PKAnalysis after LOR 

Table 3. Serial PKAnalysis after LOR 
Table 3. Serial PKAnalysis after LOR 

Sensitivity, specificity, and cutoff values during LOR and ROR are presented in table 4. During LOR, all indices were equally sensitive, with optimal cutoff points, and were approximately equally specific at the cutoff point of 100% sensitivity.

Table 4. Sensitivity and Specificity during LOR and ROR (with Standard Error) 

Table 4. Sensitivity and Specificity during LOR and ROR (with Standard Error) 
Table 4. Sensitivity and Specificity during LOR and ROR (with Standard Error) 


The results of qEEG analysis are presented in table 5. There were no significant differences between the two hemispheres, except for a physiologic slight amplitude difference in alpha band at awake in the occipital derivation, and the right hemisphere was selected for further analyses. Generally, an increase in total absolute power was detected predominantly in the frontal derivation. Slow activity in delta and theta bands increased during xenon anesthesia. There was a slight increase in the total amount of alpha activity during xenon anesthesia compared with awake baseline in the frontal region, whereas it decreased in the posterior derivation. A slight increase in beta band in frontal derivation was also detected. The 95% spectral edge frequency was significantly decreased in both occipital and frontal derivations.

Table 5. Quantitative EEG Variables at Awake and during Xenon Anesthesia 

Table 5. Quantitative EEG Variables at Awake and during Xenon Anesthesia 
Table 5. Quantitative EEG Variables at Awake and during Xenon Anesthesia 


The mean vital and hemodynamic variables at awake, during induction, and steady-state anesthesia are presented in table 6. Generally, both blood pressure and heart rate increased during induction and, later, in response to intubation. On average, intubation increased the mean arterial pressure by 12.0 mmHg (95% CI 5.3–18.8) and heart rate by 18.9 beats/min (CI 9.3–28.5) (table 7). After steady-state anesthesia was achieved, blood pressure and heart rate returned to slightly below their respective baseline values and thereafter remained unchanged throughout anesthesia. Hypotension (defined as a decrease of more than 30% of baseline values in systolic or mean arterial pressure) was not observed in any of the subjects.

Table 6. Vital Parameters during Xenon Induction and Anesthesia 

Table 6. Vital Parameters during Xenon Induction and Anesthesia 
Table 6. Vital Parameters during Xenon Induction and Anesthesia 

Table 7. Hemodynamic Response to Intubation 

Table 7. Hemodynamic Response to Intubation 
Table 7. Hemodynamic Response to Intubation 

Adverse Events

No serious adverse events were observed. Five subjects (27.8%) became agitated (muscle rigidity or an attempt to move vigorously) immediately before LOR during the induction. Muscle rigidity was severe enough to make manual ventilation difficult. Eight subjects (47.0%) suffered from nausea during recovery. Despite antiemetic therapy, three subjects (17.6%) vomited. Two subjects (11.8%) experienced hallucinations. None of the subjects reported any memories or recalls that could be considered indicative of awareness during anesthesia on the structured questionnaire.

The present study shows some limitations of BIS and Entropy to monitor the depth of sedation during xenon anesthesia. Both EEG-derived indices showed a delay to detect LOR during induction of xenon anesthesia. Moreover, the values of ROR were lower than the values of LOR. However, both monitors performed well in distinguishing between conscious and unconscious states during steady-state anesthesia. Xenon anesthesia induced changes in raw EEG, which surprisingly closely resemble those induced by propofol.26These changes included increased amplitude and slowing of the signal with frontal area dominance.

Although the exact mechanism of the anesthetic action of xenon is still to be determined, it is thought that xenon exerts its effects by antagonism of glutamatergic neurotransmission27mediated via  the NMDA receptor and, as recently proposed, possibly also via  the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and kainate subtypes of glutamate receptors.28Most of the anesthetics act by enhancing the inhibitory γ-aminobutyric acid type A transmission, and anesthesia depth indices have been validated for several hypnotics of this type. However, these indices may perform worse or even fail with NMDA antagonists such as ketamine.29 

The utility of anesthesia depth monitors during xenon anesthesia has been questioned as low BIS values did not necessarily indicate adequate hypnosis in a study by Goto et al.  16However, the performance analysis for BIS was executed only at emergence from anesthesia. In addition, the observed discrepancy between BIS and clinically determined consciousness could have been a consequence from the remaining slow EEG because of the residual anesthetic effect indicated by low 95% spectral edge frequency in that study. Accordingly, our data demonstrated lower values for BIS and Entropy at ROR than at awake. Other means of anesthetic depth assessments, such as the middle latency auditory-evoked potentials, have been shown to possibly be useful in monitoring hypnosis during xenon anesthesia.30 

BIS and Entropy use different mathematical principles to transform the changes in EEG signals into a practical scoring system. Comparative studies between the usefulness of BIS and Entropy have been performed with sevoflurane and propofol.31–33Both indices have been similarly reliable in the models tested. Accordingly, in the present study, there were no differences in the performance of these monitors at any time points in the PKanalysis. BIS, SE, and RE demonstrated low PKvalues at LOR, but by 1 min after LOR, the values were already high, which demonstrates the delay observed in detecting LOR. An increase in all three indices was detected after the initial decrease, which may be related to painful stimulus caused by intubation. After steady state was achieved, all indices remained below their corresponding cutoff values, and importantly, the clinical status correlated uniformly with the information obtained from both monitors in our study. None of the subjects reported possible awareness during anesthesia. At emergence, the performance of these monitors was good in the analyses, although lower absolute values for these indices were observed at ROR than at LOR. Interestingly, the median value for SE at ROR was as low as 41, a value that is in the range for surgical anesthesia. Good performance in the analyses might be explained by the very low values during steady state, indicative of deep sedation. However, the performance in our study was tested only at few time points, and our healthy volunteers were not subjected to painful interventions, which resulted in quite low values in the indices during steady-state anesthesia.

It has been reported that instant change in an artificial EEG signal causes a 14-s lag in BIS to change from values indicating awareness to values indicating surgical hypnosis.34It can therefore be assumed that, in addition to the computational delay, other causes for delay may exist. In our study, there was a rather wide interindividual variability in the time between the LOR and the index number indicating unconscious state. Agitation with ensuing muscle tone for some subjects may have caused this variability.

The actual changes in the raw EEG signal should always be considered when evaluating the usefulness of EEG-derived indices. For instance, the poor performance of these monitors with ketamine29has been associated with a different profile of ketamine-induced EEG power spectral changes compared with anesthetics acting via γ-aminobutyric acid type A receptors.26In earlier EEG studies, subanesthetic xenon has been shown to induce a decrease in alpha and beta activity and an increase in theta activity with unchanged delta band.35,36However, there are much less data about the effects of surgical concentrations of single-agent xenon on the EEG spectrum. It has been shown in three healthy subjects that xenon inhalation, at concentrations sufficient to cause unconsciousness, increased theta and gamma activity with no change in the delta band.17In that study, the subjects were allowed to recover immediately after LOR; therefore, a steady anesthetic state was likely not achieved. This may have caused the difference in the delta band between those previous observations and our findings. In fact, qEEG in the present study showed changes that resemble those induced by propofol.26An increase in total power with frontal predominance was also observed in our study. In addition to increased power in the slow frequency bands, a relative increase in the alpha band was seen in the frontal areas. This finding is in strict contradiction to those observed during ketamine anesthesia.29Recently, it has been suggested that the anesthetic mechanism of xenon might in fact differ from that of ketamine.37It has been shown that xenon anesthesia induces a reduction in both regional cerebral glucose metabolism and blood flow.18,37Ketamine induces quite different effects on cerebral metabolism and blood flow.38Because the profile of EEG changes during xenon anesthesia are closer to those induced by propofol than those induced by NMDA-antagonistic regimens, the assumptions of different mechanism of action compared with other NMDA-antagonists are indirectly supported.

Xenon anesthesia has been shown to be associated with better preserved blood pressure and heart rate than, e.g. , isoflurane-nitrous oxide or propofol anesthesia,3,39even in patients with compromised myocardium.4Similarly, in the present study, the induction and maintenance of anesthesia with xenon were associated with minor hemodynamic changes. In our subjects, 1.0 MAC anesthesia was not quite sufficient to blunt all hemodynamic responses to laryngoscopy and tracheal intubation. Indeed, it has been suggested that the 1.0 MAC value for xenon in young men might be closer to 70%.14Six of our 17 subjects received a single bolus of the short-acting opioid remifentanil to attenuate the pain reaction induced by intubation. Considering the mean time interval between the opioid bolus and the extremely short half-life of remifentanil (approximately 3 min in healthy young men)40, it is unlikely that it would have affected the results. However, this possibility was taken into consideration in the statistical analysis of BIS, Entropy, and hemodynamic data; importantly, remifentanil did not affect the results.

In an earlier study, the mean induction time with xenon was 71 s.15The significantly longer time to LOR in the present study is most likely the result of the properties of the PhysioFlex ventilator. It is not designed for mask induction, and the concentration of xenon increased slowly. The very fast emergence from xenon anesthesia is a logical result from the low blood/gas partition coefficient, and it has also been observed earlier.3Induction with xenon caused agitation in five subjects, again an effect observed previously, predominantly in men.14In our study, the frequency of nausea and vomiting was high, which has also been reported in other studies.41Agitation and nausea may be related to NMDA antagonism, similar to ketamine.42 

In conclusion, BIS and SE performed well after steady state was achieved, but during induction and emergence, there were delays in detecting the clinical state. These results should be extrapolated with caution to a clinical setting as the volunteers were not subjected to noxious stimuli in our study. Surprisingly, xenon-induced changes in EEG closely resembled those induced by propofol.

The authors thank Per Rosenberg, M.D. (Professor, University of Helsinki, Helsinki, Finland), for suggesting the research topic and for his valuable comments concerning the manuscript. The personnel of Turku PET Centre, Turku, Finland, is acknowledged for competent technical support; Jari Turunen, M.Sc., and Tanja Huovinen, M.Sc. (4Pharma, Turku, Finland), for performing the statistical analyses; and Carsten Pilger, M.D., Peter Neu, M.D., and Paul Metten, M.B.A. (Air Liquide Deutschland GmbH, Krefeld, Germany), for their assistance in regulatory matters.

Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR: How does xenon produce anaesthesia? Nature 1998; 396:324
Tonner PH: Xenon: One small step for anaesthesia? Curr Opin Anaesthesiol 2006; 19:382–4
Coburn M, Kunitz JH, Baumert K, Hecker K, Haaf S, Zuhlsdorff A, Beeker T, Rossaint R: Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia. Br J Anaesth 2005; 94:198–202
Goto T, Hanne P, Ishiguro Y, Ichinose F, Niimi Y, Morita S: Cardiovascular effects of xenon and nitrous oxide in patients during fentanyl-midazolam anaesthesia. Anaesthesia 2004; 59:1178–83
Hartlage M, Berendes E, Van Aken H, Fobker M, Theisen M, Weber T: Xenon improves recovery from myocardial stunning in chronically instrumented dogs. Anesth Analg 2004; 99:655–64
Preckel B, Müllenheim J, Moloschavij A, Thämer V, Schlack W: Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo . Anesth Analg 2000; 91:1327–32
Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, Mehmet H, Edwards AD, Franks NP, Maze M: Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005; 58:182–93
Wilhelm S, Ma M, Maze M, Franks NP: Effects of xenon on in vitro  and in vivo  models of neuronal injury. Anesthesiology 2002; 96:1485–91
Schmidt M, Marx T, Glöggl E, Reinelt H, Schirmer U: Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology 2005; 102:929–36
Liu S: Effects of bispectral index monitoring on ambulatory anesthesia. Anesthesiology 2004; 101:311–5
Ekman A, Lindholm M-L, Lennmarken C, Sandin R: Reduction in the incidence of awareness using BIS monitoring. Acta Anesthesiol Scand 2004; 48:20–6
Hans P, Dewandre P, Brichant J, Bonhomme V: Comparative effects of ketamine on bispectral index and spectral entropy of the electroencephalogram under sevoflurane anesthesia. Br J Anaesth 2005; 94:336–40
Park K, Hur K, Han K, Kil H, Han T: Bispectral index does not correlate with observer assessment of alertness and sedation scores during 0.5 % bupivacaine epidural anesthesia with nitrous oxide sedation. Anesth Analg 2006; 103:385–9
Goto T, Nakata Y, Morita S: The minimum alveolar concentration of xenon in the elderly is sex-dependent. Anesthesiology 2002; 97:1129–32
Nakata Y, Goto T, Morita S: Comparison of inhalation inductions with xenon and sevoflurane. Acta Anesthesiol Scand 1997; 41:1157–61
Goto T, Nakata Y, Saito H, Ishiguro Y, Niimi Y, Suwa K, Morita S: Bispectral analysis of the electroencephalogram does not predict responsiveness to verbal command in patients emerging from xenon anesthesia. Br J Anaesth 2000; 85:359–63
Johnson B, Sleigh J, Kirk I, Williams M: High-density EEG mapping during general anesthesia with xenon and propofol: A pilot study. Anaesth Inensive Care 2003; 31:155–63
Laitio R, Kaisti K, Långsjö J, Aalto S, Salmi S, Maksimow A, Aantaa R, Oikonen V, Sipilä H, Parkkola R, Scheinin H: Effects of xenon anesthesia on cerebral blood flow in humans: A positron emission tomography study. Anesthesiology 2007; 106:1128–33
Nakata Y, Goto T, Ishiguro Y: Minimum alveolar concentration (MAC) of xenon with sevoflurane in humans. Anesthesiology 2001; 94:611–4
Rampil I: A primer for EEG signal processing in anesthesia. Anesthesiology 1998; 89:980–1002
Viertiö-Oja H, Maja V, Särkelä M, Talja P, Tenkanen N, Tolvanen-Laakso H, Paloheimo M, Vakkuri A, Yli-Hankala A, Meriläinen P: Description of the Entropy™ algorithm as applied in the Datex-Ohmeda S/5™ Entropy module. Acta Anesthesiol Scand 2004; 48:154–61
Suzuki A, Bito H, Sanjo Y, Katoh T, Sato S: Evaluation of the PhysioFlex™ closed-circuit anaesthesia machine. Eur J Anaesth 2000; 17:359–63
Brice DD, Hetherington R, Utting J: A simple study of awareness and dreaming during anesthesia. Br J Anaesth 1970; 42:535–42
Smith WD, Dutton RC, Smith NT: Measuring the performance of anesthetic depth indicators. Anesthesiology 1996; 84:38–51
Drummond JC: Monitoring depth of anesthesia: with emphasis on the application of the bispectral index and the middle latency auditory evoked responses to the prevention of recall. Anesthesiology 2000; 93:876–82
Gugino L, Chabot R, Prichep L, John E, Formanek V, Aglio L: Quantitative EEG changes associated with loss and return of consciousness in healthy adult volunteers anaethetized with propofol or sevoflurane. Br J Anaesth 2001; 87:421–8
Nagele P, Metz L, Crowder M: Xenon acts by inhibition of non-N -methyl-aspartate receptor-mediated glutamatertic neurotransmission in caenorhabditis elegans. Anesthesiology 2005; 103:508–13
Dinse A, Föhr KJ, Geogieff M, Beyer C, Bulling A, Weigt HU: Xenon reduces glutamate-, AMPA and kainate-induced membrane currents in cortical neurones. Br J Anaesth 2005; 94:479–85
Maksimow A, Särkelä M, Längsjö J, Salmi E, Kaisti K, Yli-Hankala A, Hinkka-Yli-Salomäki S, Scheinin H, Jääskeläinen S: Increase in high frequency EEG activity explains poor performance of EEG spectral entropy monitor during S-ketamine anesthesia. Clin Neurophysiol 2006; 117:1660–8
Goto T, Nakata Y, Saito H, Ishiguro Y, Niimi Y, Morita S: The midlatency auditory evoked potentials predict responsiveness to verbal commands in patients emerging from anesthesia with xenon, isoflurane, and sevoflurane but not with nitrous oxide. Anesthesiology 2001; 94:782–9
Ellerkmann RK, Liebermann VM, Alves TM, Wenningmann I, Kreuer S, Wilhelm W, Roepcke H, Hoeft A, Bruhn J: Spectral entropy and bispectral index as measures of the electroencephalographic effects of sevoflurane. Anesthesiology 2004; 101:1275–82
Takamatsu I, Ozaki M, Kazama T: Entropy indices versus  the bispectral index estimating nociception during sevoflurane anaesthesia. Br J Anaesth 2006; 96:620–6
Schmidt GN, Bishoff P, Standl T, Hellstern A, Teuber O, Schulte am Esch J: Comparative evaluation of the Datex-Ohmeda S/5 Entropy module and the Bispectral Index® Monitor during propofol-remifentanil anesthesia. Anesthesiology 2004; 101:1283–90
Pilge S, Zanner R, Schneider G, Blum J, Kreuzer M, Kochs E: Time delay of index calculation. Anesthesiology 2006; 104:488–94
Hartmann A, Dettmers C, Schuier F, Wassmann H, Schumacher H: Effect of stable xenon on regional cerebral blood flow and the electroencephalogram in normal volunteers. Stroke 1991; 22:182–9
Holl K, Samii M, Gaab M, Kohmura E, Nemati N: EEG changes during five minutes of inhalation of a 33 % xenon-O2mixture. Neurosurg Rev 1987; 10:309–10
Rex S, Schaefer W, Meyer P, Rossaint R, Boy C, Setani K, Bull U, Baumert J: Positron emission tomography study of regional cerebral metabolism during general anesthesia with xenon in humans. Anesthesiology 2006; 105:936–43
Längsjö JW, Maksimow A, Syrjänen E, Kaisti KK, Aalto S, Oikonen V, Hinkka S, Aantaa R, Sipilä H, Viljanen T, Parkkola R, Scheinin H: S-Ketamine anesthesia increases cerebral blood flow in excess to the metabolic needs in humans. Anesthesiology 2005; 103:258–68
Rossaint R, Reyle-Hahn M, Schulte am Esch J, Scholz J, Scherpereel P, Vallet B, Giunta F, Del Turco M, Erfmann W, Tenbrinck R, Hammerle AE, Nagele P: Xenon Study Group: Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003; 98:6–13
Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Schafer SL: Remifentanil versus  alfentanil: Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996; 84:821–33
Petersen-Felix S, Luginbühl M, Schnider TW, Curatolo M, Arendt-Nielsen L, Zbinden AM: Comparison of the analgesic potency of xenon and nitrous oxide in humans evaluated by experimental pain. Br J Anaesth 1998; 81:742–7
Elia N, Tramer MR: Ketamine and postoperative pain: A quantitative systematic review of randomised trials. Pain 2005; 113:61–70